Valuation DexCom, Inc. Mexican S.E.
Stocks
DXCM *
US2521311074
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Mexican S.E.
2026-08-21
|
5-day change | 1st Jan Change | ||
| 1,529.00 MXN | -0.57% |
|
-.--% | +26.05% |
| 08-24 | Dexcom Insider Sold Shares Worth $2,408,242, According to a Recent SEC Filing | MT |
| 08-13 | Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating | MT |
Company Valuation: DexCom, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 52,042 | 43,740 | 47,945 | 30,377 | 25,885 | 33,170 | - | - |
| Change | - | -15.95% | 9.61% | -36.64% | -14.79% | 28.14% | - | - |
| Enterprise Value (EV) 1 | 52,692 | 45,068 | 49,813 | 31,073 | 26,209 | 32,409 | 32,109 | 31,293 |
| Change | - | -14.47% | 10.53% | -37.62% | -15.65% | 23.66% | -0.93% | -2.54% |
| P/E | 346x | 138x | 95.5x | 54.8x | 31.8x | 35.2x | 29.6x | 24.4x |
| PBR | 23.1x | 20.5x | 23.1x | 15.1x | 9.3x | 11.7x | 9.73x | 7.48x |
| PEG | - | 1x | 1.6x | 5.94x | 0.7x | 1.8x | 1.6x | 1.2x |
| Capitalization / Revenue | 21.3x | 15x | 13.2x | 7.53x | 5.55x | 6.34x | 5.72x | 5.13x |
| EV / Revenue | 21.5x | 15.5x | 13.8x | 7.7x | 5.62x | 6.2x | 5.54x | 4.84x |
| EV / EBITDA | 111x | 60x | 49.1x | 28.1x | 19.4x | 19.5x | 16.7x | 14.1x |
| EV / EBIT | 142x | 92.9x | 69.3x | 41x | 27x | 26x | 22.2x | 18.2x |
| EV / FCF | 989x | 148x | 97.3x | 49.3x | 24.3x | 31.7x | 26.3x | 21.3x |
| FCF Yield | 0.1% | 0.68% | 1.03% | 2.03% | 4.11% | 3.15% | 3.8% | 4.7% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 0.3875 | 0.82 | 1.3 | 1.42 | 2.09 | 2.495 | 2.969 | 3.596 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,448 | 2,910 | 3,622 | 4,033 | 4,662 | 5,230 | 5,800 | 6,461 |
| EBITDA 1 | 472.7 | 751.6 | 1,014 | 1,105 | 1,349 | 1,666 | 1,920 | 2,218 |
| EBIT 1 | 370.7 | 485.1 | 718.6 | 757.1 | 969.3 | 1,247 | 1,445 | 1,722 |
| Net income 1 | 154.7 | 341.2 | 541.5 | 576.2 | 836.3 | 974.4 | 1,149 | 1,409 |
| Net Debt 1 | 650.1 | 1,328 | 1,868 | 695.9 | 323.2 | -761.1 | -1,061 | -1,877 |
| Reference price 2 | 134.24 | 113.24 | 124.09 | 77.77 | 66.37 | 87.90 | 87.90 | 87.90 |
| Nbr of stocks (in thousands) | 387,688 | 386,258 | 386,374 | 390,595 | 390,016 | 377,361 | - | - |
| Announcement Date | 2/10/22 | 2/9/23 | 2/8/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 31.08x | 4.2x | 16.15x | 2.37% | 187B | |
| 19.92x | 3.63x | 12.95x | 3.01% | 120B | |
| 18.12x | 0.21x | 13.19x | 0.72% | 63.15B | |
| 29.59x | 7.29x | 18.82x | 1.35% | 51.75B | |
| 35.6x | 3.43x | 11.76x | 2.12% | 50.32B | |
| 35.23x | 6.2x | 19.45x | -.--% | 33.17B | |
| 47.24x | 1.35x | 12.52x | 0.2% | 32.1B | |
| 39.65x | 6.94x | 24.91x | 0.27% | 23.93B | |
| 18.12x | 2.89x | 10.23x | 1.53% | 22.99B | |
| Average | 30.51x | 4.02x | 15.55x | 1.29% | 65.03B | |
| Weighted average by Cap. | 28.60x | 3.88x | 15.15x | 1.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DXCM Stock
- DXCM * Stock
- Valuation DexCom, Inc.
Select your edition
All financial news and data tailored to specific country editions
